Clinical Trial

Prospective Clinical Assessment Study in Children With Hypochondroplasia

Name: Prospective Clinical Assessment Study in Children With Hypochondroplasia — clinical trial record (NCT06410976)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HCH

Recruiting

View on ClinicalTrials.gov →

Summary

This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).

Protocol Amendment History 16 amendments

This ClinicalTrials.gov record has been amended 16 times since 2024-05-08; most recent amendment 2026-07-14.

Trial Details

NCT Number	NCT06410976
Lead Sponsor	QED Therapeutics, a BridgeBio company
Conditions	Hypochondroplasia
Enrollment	150 participants
Start Date	2024-06-05
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-16